Increased choices of pneumococcal vaccines for policy makers.

Streptococcus pneumoniae is a bacterial disease estimated to be the cause of death of 294 000 children aged 1–59 months worldwide in 2015.1 As a result, many health agencies have published recommendations to handle invasive pneumococcal disease.